Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell lines

Heejoon Chae, Sangseon Lee, Kenneth Nephew, Sun Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Aberrant epigenetic modifications, including DNA methylation, are key regulators of gene activity in tumorigenesis. Breast cancer is a heterogeneous disease, and large-scale analyses indicate that tumor from normal and benign tissues, as well as molecular subtypes of breast cancer, can be distinguished based on their distinct genomic, transcriptomic, and epigenomic profiles. In this study, we used affinity-based methylation sequencing data in 30 breast cancer cell lines representing functionally distinct cancer subtypes to investigate methylation and mutation patterns at the whole genome level. Results: Our analysis revealed significant differences in CpG island (CpGI) shore methylation and mutation patterns among breast cancer subtypes. In particular, the basal-like B type, a highly aggressive form of the disease, displayed distinct CpGI shore hypomethylation patterns that were significantly associated with downstream gene regulation. We determined that mutation rates at CpG sites were highly correlated with DNA methylation status and observed distinct mutation rates among the breast cancer subtypes. These findings were validated by using targeted bisulfite sequencing of differentially expressed genes (n=85) among the cell lines. Conclusions: Our results suggest that alterations in DNA methylation play critical roles in gene regulatory process as well as cytosine substitution rates at CpG sites in molecular subtypes of breast cancer.

Original languageEnglish (US)
Article number116
JournalBMC Systems Biology
Volume10
DOIs
StatePublished - Dec 23 2016

Fingerprint

CpG Islands
Methylation
Breast Cancer
Mutation
Genes
Cells
Breast Neoplasms
Cell Line
Line
Cell
DNA Methylation
Distinct
Mutation Rate
Regulator Genes
Gene
Epigenomics
Sequencing
Gene expression
Tumors
Substitution reactions

Keywords

  • Breast cancer
  • CpGI shore
  • DNA methylation
  • Mutation
  • Subtype

ASJC Scopus subject areas

  • Structural Biology
  • Modeling and Simulation
  • Molecular Biology
  • Computer Science Applications
  • Applied Mathematics

Cite this

Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell lines. / Chae, Heejoon; Lee, Sangseon; Nephew, Kenneth; Kim, Sun.

In: BMC Systems Biology, Vol. 10, 116, 23.12.2016.

Research output: Contribution to journalArticle

@article{a639587119814c0f92f563baf3fde38b,
title = "Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell lines",
abstract = "Background: Aberrant epigenetic modifications, including DNA methylation, are key regulators of gene activity in tumorigenesis. Breast cancer is a heterogeneous disease, and large-scale analyses indicate that tumor from normal and benign tissues, as well as molecular subtypes of breast cancer, can be distinguished based on their distinct genomic, transcriptomic, and epigenomic profiles. In this study, we used affinity-based methylation sequencing data in 30 breast cancer cell lines representing functionally distinct cancer subtypes to investigate methylation and mutation patterns at the whole genome level. Results: Our analysis revealed significant differences in CpG island (CpGI) shore methylation and mutation patterns among breast cancer subtypes. In particular, the basal-like B type, a highly aggressive form of the disease, displayed distinct CpGI shore hypomethylation patterns that were significantly associated with downstream gene regulation. We determined that mutation rates at CpG sites were highly correlated with DNA methylation status and observed distinct mutation rates among the breast cancer subtypes. These findings were validated by using targeted bisulfite sequencing of differentially expressed genes (n=85) among the cell lines. Conclusions: Our results suggest that alterations in DNA methylation play critical roles in gene regulatory process as well as cytosine substitution rates at CpG sites in molecular subtypes of breast cancer.",
keywords = "Breast cancer, CpGI shore, DNA methylation, Mutation, Subtype",
author = "Heejoon Chae and Sangseon Lee and Kenneth Nephew and Sun Kim",
year = "2016",
month = "12",
day = "23",
doi = "10.1186/s12918-016-0356-2",
language = "English (US)",
volume = "10",
journal = "BMC Systems Biology",
issn = "1752-0509",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell lines

AU - Chae, Heejoon

AU - Lee, Sangseon

AU - Nephew, Kenneth

AU - Kim, Sun

PY - 2016/12/23

Y1 - 2016/12/23

N2 - Background: Aberrant epigenetic modifications, including DNA methylation, are key regulators of gene activity in tumorigenesis. Breast cancer is a heterogeneous disease, and large-scale analyses indicate that tumor from normal and benign tissues, as well as molecular subtypes of breast cancer, can be distinguished based on their distinct genomic, transcriptomic, and epigenomic profiles. In this study, we used affinity-based methylation sequencing data in 30 breast cancer cell lines representing functionally distinct cancer subtypes to investigate methylation and mutation patterns at the whole genome level. Results: Our analysis revealed significant differences in CpG island (CpGI) shore methylation and mutation patterns among breast cancer subtypes. In particular, the basal-like B type, a highly aggressive form of the disease, displayed distinct CpGI shore hypomethylation patterns that were significantly associated with downstream gene regulation. We determined that mutation rates at CpG sites were highly correlated with DNA methylation status and observed distinct mutation rates among the breast cancer subtypes. These findings were validated by using targeted bisulfite sequencing of differentially expressed genes (n=85) among the cell lines. Conclusions: Our results suggest that alterations in DNA methylation play critical roles in gene regulatory process as well as cytosine substitution rates at CpG sites in molecular subtypes of breast cancer.

AB - Background: Aberrant epigenetic modifications, including DNA methylation, are key regulators of gene activity in tumorigenesis. Breast cancer is a heterogeneous disease, and large-scale analyses indicate that tumor from normal and benign tissues, as well as molecular subtypes of breast cancer, can be distinguished based on their distinct genomic, transcriptomic, and epigenomic profiles. In this study, we used affinity-based methylation sequencing data in 30 breast cancer cell lines representing functionally distinct cancer subtypes to investigate methylation and mutation patterns at the whole genome level. Results: Our analysis revealed significant differences in CpG island (CpGI) shore methylation and mutation patterns among breast cancer subtypes. In particular, the basal-like B type, a highly aggressive form of the disease, displayed distinct CpGI shore hypomethylation patterns that were significantly associated with downstream gene regulation. We determined that mutation rates at CpG sites were highly correlated with DNA methylation status and observed distinct mutation rates among the breast cancer subtypes. These findings were validated by using targeted bisulfite sequencing of differentially expressed genes (n=85) among the cell lines. Conclusions: Our results suggest that alterations in DNA methylation play critical roles in gene regulatory process as well as cytosine substitution rates at CpG sites in molecular subtypes of breast cancer.

KW - Breast cancer

KW - CpGI shore

KW - DNA methylation

KW - Mutation

KW - Subtype

UR - http://www.scopus.com/inward/record.url?scp=85006934229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006934229&partnerID=8YFLogxK

U2 - 10.1186/s12918-016-0356-2

DO - 10.1186/s12918-016-0356-2

M3 - Article

C2 - 28155687

AN - SCOPUS:85006934229

VL - 10

JO - BMC Systems Biology

JF - BMC Systems Biology

SN - 1752-0509

M1 - 116

ER -